A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients (VTEH)

January 10, 2022 updated by: Xiao Tang, Beijing Chao Yang Hospital
The purpose of this study is to analyze the effect of the prophylaxis of venous thromboembolism in the critical ill patients, and at the same time, to find out the risk of venous thromboembolism and hemorrhage events occurred under the prophylaxis.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

1114

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Beijing
      • Beijing, Beijing, China, 100020
        • Department of respiratory and critical care medicine,Beijing Chao-yang Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

the critical ill patients in ICUs

Description

Inclusion Criteria:

  • all the patients in ICUs estimated time in ICU mare than 48h

Exclusion Criteria:

  • estimated time in ICU less than 48h refused to attend

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the incidence of venous thromboembolism under the thromboprophylaxis in critical ill patients
Time Frame: 2 weeks
at the same time, to analyze the risk factor of the occurrence of venous thromboembolism despite of thromboprophylaxis
2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the incidence of bleeding events under thromboprophylaxis in critical ill patients
Time Frame: 2 weeks
at the same time, to analyze the risk factors of bleeding in critical ill patients who receive thromboprophylaxis
2 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
the incidence of venous thromboembolism under the mechanical thromboprophylaxis in the critical ill patients who with the contraindications to anticoagulation
Time Frame: 2 weeks

At the same time,to analyze the aspects below:

  1. Evaluation the tolerance to mechanical thromboprophylaxis of these patients
  2. Comparison of the effectiveness between intermittent pneumatic compression and graduated compression stockings in mechanical thromboprophylaxis
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Beijing Chao Yang Hospital

Investigators

  • Principal Investigator: Xiao Tang, MD, Beijing Chao-Yang Hospital,China

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 1, 2014

Primary Completion (ACTUAL)

December 1, 2021

Study Completion (ACTUAL)

December 1, 2021

Study Registration Dates

First Submitted

August 7, 2014

First Submitted That Met QC Criteria

August 8, 2014

First Posted (ESTIMATE)

August 12, 2014

Study Record Updates

Last Update Posted (ACTUAL)

January 11, 2022

Last Update Submitted That Met QC Criteria

January 10, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ICU-VTE-2014

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemorrhage

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe